THYROCARE vs VIJAYA: Stock Comparison
VIJAYA DIAGNOSTIC CEN is the larger company by market capitalisation. THYROCARE TECH shows a lower P/E, a higher ROE and a higher dividend yield, while VIJAYA DIAGNOSTIC CEN shows faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
THYROCARE leads 6; VIJAYA leads 6 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | THYROCARE | VIJAYA |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Healthcare Service Provider | Healthcare Service Provider |
Price
| Metric | THYROCARE | VIJAYA |
|---|---|---|
| Live Price | ₹498.25 | ₹1,410.1 |
| Day Change | 2.1% | -0.39% |
| Volume | 2.22 L | 55,287 |
| 52-Week High | ₹1,610 | ₹1,593.6 |
| 52-Week Low | ₹342.55 | ₹848 |
| Distance from 52W High | -69.05% | -11.51% |
Valuation
| Metric | THYROCARE | VIJAYA |
|---|---|---|
| Market Cap | ₹7,926 Cr | ₹14,449 Cr |
| P/E Ratio | 54.97x | 70.88x |
| P/B Ratio | 14.32x | 13.65x |
| EPS | ₹1 | ₹5.77 |
| Book Value | ₹36.82 | ₹92.93 |
| Dividend Yield | 1.41% | 0.14% |
Growth
| Metric | THYROCARE | VIJAYA |
|---|---|---|
| Revenue Growth (TTM YoY) | 19.7% | 26.6% |
| EPS Growth (TTM YoY) | 116.3% | 38% |
| Qtr Sales Growth | 12.83% | 10.57% |
| Qtr Profit Growth | -70.35% | 12% |
Profitability & Leverage
| Metric | THYROCARE | VIJAYA |
|---|---|---|
| ROE | 26.54% | 18.86% |
| ROCE | 28.32% | 22.72% |
| Net Margin | 19.67% | 20.91% |
| Operating Margin | 27.46% | 34.93% |
| Debt to Equity | 0x | 0x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | THYROCARE | VIJAYA |
|---|---|---|
| Promoter Holding | 51.02%▼ 9.9 pp | 52.46%▼ 0.01 pp |
| FII Holding | 9.37%▲ 3.93 pp | 10.66%▼ 0.99 pp |
| DII Holding | 25.92%▲ 5 pp | 32.5%▲ 0.92 pp |
| Public Holding | 13.7%▲ 0.98 pp | 4.38%▲ 0.07 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: THYROCARE TECH and VIJAYA DIAGNOSTIC CEN.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.

